Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS: Phase II
Description
Grant Amounts: The US Department of Health and Human Services, Centers for Disease Control and Prevention is providing an estimated total of $64,000,000 in funding for this grant. Phase I of this program (CDC-RFA-PS10-10181) supported the development and initial implementation of Enhanced Comprehensive HIV Prevention Plans (ECHPPs) for MSAs most affected by the HIV epidemic in order to reduce HIV risk and incidence in those areas. In Phase II, which will be supported under this FOA (CDC-RFA-PS11-1117), all adequately performing jurisdictions funded under Phase I that are responsive to this FOA will be selected to further support coordination and implementation of their ECHPPs over a two-year project period.
The FOA includes two components: Part A – ECHPP Coordination and Evaluation; and Part B – ECHPP Implementation. Part A will support grantees’ efforts to (1) administer and manage cross-agency coordination efforts, including partnerships and funding streams to better leverage prevention, care, and treatment resources; and (2) administer and manage data coordination, which could include activities ranging from the development of common measures to development of integrated data systems to be able to collect relevant data to monitor jurisdictional progress on goals consistent with the National HIV/AIDS Strategy, including data reporting to CDC and other stakeholders. Part B will support additional implementation of “Required” and “Recommended” ECHPP activities (Appendix 1) as described in the previous Funding Opportunity Announcement CDC-RFA-PS10-10181 or other strategies or interventions included in the jurisdiction’s CDC-approved Enhanced Plan. Applicants may apply for both Part A and Part B or for Part A only. Applicants cannot apply for Part B only.
Funding Organization
National Center for US Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
Fund Category
HIV/AIDS
Support Types
Cooperative Agreements
Locations
California District of Columbia Florida Georgia Illinois Maryland New York Pennsylvania Puerto Rico Texas
Fund Location Note
Applicants eligible to apply for this cooperative agreement are limited to twelve (12) entities in specific Metropolitan Statistical Areas (MSAs) or specified Metropolitan Divisions (MDs) that have the highest estimated AIDS prevalence at the end of 2007. These twelve eligible areas received funding for Phase I of the project under announcement CDC-RFA-PS10-10181.
The entities eligible to apply for funds under this FOA are listed as follows, with the eligible applicant listed first and then the corresponding MSA/MD: 1. New York City Department of Health and Mental Hygiene, New York Division; 2. Los Angeles County Public Health Department, Los Angeles Division; 3. District of Columbia Department of Health, Washington Division; 4. Chicago Department of Public Health, Chicago Division; 5. Georgia Department of Human Resources, Atlanta-Sandy Springs-Marietta, GA; 6. Florida State Department of Health, Miami Division; 7. City of Philadelphia Public Health Department, Philadelphia Division; 8. Houston Department of Health and Human Services, Houston-Baytown-Sugar Land, TX; 9. San Francisco Department of Public Health, San Francisco Division; 10. Maryland State Department of Health, Baltimore-Towson, MD; 11. Texas State Department of Health Services, Dallas Division; and 12. Puerto Rico Department of Health, San Juan-Caguas-Guaynabo, PR.
Eligible Organizations
State Agencies
Award Date
9/30/2011
Number of Awards Given
12
Award Amount
$64,000,000
Award Amount Notes
For details about the funding amounts per year and for formulas for Parts A and B, please see the grant announcement at http://www07.grants.gov/search/search.do;jsessionid=nTg2NMSXMnfdvjnbxzdSqzzDHNTXZGl2M8G3hT8TjJrqvFFq4lTM!-2077849862?oppId=82433&mode=VIEW.
Application Due Date
5/25/2011
Application Contact
Patricia French Grants Management Specialist DHHS CDC Procurement & Grants Office 2920 Brandywine Rd MS E-15 Atlanta, GA 30341 Phone: (770) 488-2849
Technical Contact
Stephen Flores Project Officer DHHS CDCDHAP Office of the Director 1600 Clifton Rd., MS E-37 Atlanta, GA 30333 Phone: (404) 639-1910
Fund Duration
2 Years.
Subjects
Health Care Planning Health Care Programs/Services Hepatitis Prevention HIV/AIDS Prevention Program Evaluation Program Management Statistics STD Prevention TB Prevention
Audiences
At Risk Persons At Risk Youth Clinics Health Services Organizations Local Government Agencies Low Income Persons Minorities Persons with Hepatitis Persons with HIV/AIDS Persons with STDs Persons with TB State Government Agencies
Application Process
Applications must be submitted electronically at www.Grants.gov. Electronic applications will be considered as having met the deadline if the application has been successfully made available to CDC for processing from Grants.gov on the deadline date. The application package can be downloaded from www.Grants.gov. Applicants can complete the application package off-line, and then upload and submit the application via the Grants.gov Web site. The applicant must submit all application attachments using a PDF file format when submitting via Grants.gov. Directions for creating PDF files can be found on the Grants.gov Web site. Use of file formats other than PDF may result in the file being unreadable by staff.
Applications submitted through Grants.gov (http://www.grants.gov), are electronically time/date stamped and assigned a tracking number. The AOR will receive an e-mail notice of receipt when Grants.gov receives the application. The tracking number serves to document submission and initiate the electronic validation process before the application is made available to CDC for processing.
For details about the application procedures for this funding opportunity, please see the grant announcement at http://www07.grants.gov/search/search.do;jsessionid=nTg2NMSXMnfdvjnbxzdSqzzDHNTXZGl2M8G3hT8TjJrqvFFq4lTM!-2077849862?oppId=82433&mode=VIEW.
Notes
This announcement supports integration of diagnostic and prevention services for the Human Immunodeficiency Virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), sexually transmitted diseases (STD); and tuberculosis (TB) because of CDC's greater understanding of the extent to which: • STDs increase the risk for HIV infection. • Control of TB, viral hepatitis, and STDs is needed to protect the health of HIV-infected persons. • HIV, viral hepatitis and STDs share common risks and modes of transmission. • Risks for acquiring theses diseases are associated with similar behaviors and environmental conditions and have reciprocal or interdependent effects. • Clinical course and outcomes of these diseases are influenced by co-infection (for example, HIV/TB can be deadly, and TB accelerates HIV disease progression). • Populations disproportionately affected by HIV are also disproportionately affected by infections with TB, HCV, HBV, and STDs.
Details of this strategy and approach are outlined in the NCHHSTP White Paper which can be found at http://www.cdc.gov/nchhstp/programintegration.
Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.
